PGEN Stock Analysis: Buy, Sell, or Hold?
PGEN - Precigen, Inc. Common Stock
$5.64
0.39 (7.43%)
▲
5d:
+2.17%
30d:
+46.11%
90d:
+43.51%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Smart Money Accumulation
None View Scanner →
Strength: 5.6/10
Get Alerted When PGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PGEN shows positive signals but monitor for confirmation. Market pricing in 16.4% decline. Moderate conviction.
💡 BUY OPPORTUNITY: PGEN shows positive signals but monitor for confirmation. Market pricing in 16.4% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.01
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.35
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PGEN is currently trading at $5.64, which is considered extended relative to its 30-day fair value range of $3.94 to $5.40. From a valuation perspective, the stock is trading at a discount (Forward PE: 28.2) compared to its historical average (48.3). Remarkably, the market is currently pricing in an annual earnings decline of 16.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, PGEN is in a strong uptrend. Immediate support is located at $4.59, while resistance sits at $6.04. The stock is showing strong short-term momentum, up 7.4% recently.
Market Sentiment: PGEN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.45 (+120.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PGEN is in a strong uptrend. Immediate support is located at $4.59, while resistance sits at $6.04. The stock is showing strong short-term momentum, up 7.4% recently.
Market Sentiment: PGEN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.45 (+120.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.94 -
$5.40
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.4%)
- BULLISH: Trading 120.7% below Wall St target ($12.45)
Trading Range Analysis
30-Day Trading Range
$3.94 -
$5.40
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.59
Resistance Level
$6.04
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.20
Wall Street Target
$12.45
(+120.7%)
Revenue Growth (YoY)
1633.9%
Valuation Discount vs History
-16.4% cheaper
PE vs Historical
28.2 vs 48.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.4%
(market-implied from PE analysis)
1-Year Target
$5.08
(-10%)
2-Year Target
$4.57
(-19%)
3-Year Target
$4.11
(-27%)
3-Yr Target (if PE normalizes)
(PE: 28→48)
$7.04
(+25%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 28.2 to 48.3
Stabilization Target:
$9.66
(+71.3%)
PE Expansion Potential:
+71.3%
Share & Embed Analysis
Last updated: July 04, 2026 1:17 AM ET
Data refreshes hourly during market hours. Next update: 2:17 AM
Data refreshes hourly during market hours. Next update: 2:17 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Randal J Kirk
SELL
4772781 shares
2026-03-30
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 64 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 56 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 62 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 58 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
Advanced PGEN Option Strategies
Professional options setups generated by AI based on today's PGEN price and gamma walls.
